E Q U I T Y A N D L I A B I L I T I E S

Sartorius Lab Holding GmbH, Goettingen, Germany Balance Sheet for the Year Ended December 31, 2011 A S S E T S E Q U I T Y A N D L I A B I L I T I E S Notes Dec. 31, 2011 Dec. 31, 2010 Notes Dec. 31, 2011 Dec. 31, 2010 in K in K in K in K A. Assets A. Equity and liabilities Financial assets (4) 153,769.987.74 0 I. Issued capital (6) 5,000,000.00 25 II. Capital reserves (6) 144,581,457.59 0 IV. Retained loss incl. net loss (8) -1,654,445.98 0 B. Current assets 147,927,011.61 25 I. Trade and other receivables (5) 67,031,870.47 0 B. Provisions (9) 322,000.00 0 II. Cash on hand, C. Liabilities (10) 72,622,552.89 0 deposits in banks 517,634.29 25 67,549,504.76 221,319,492.50 25 221,319,492.50 25

Sartorius Lab Holding GmbH, Goettingen, Germany Notes to the Financial Statements for the Year Ended December 31, 2011 In February of fiscal 2011, the name of the company Sartorius Beteiligungs-GmbH was changed to Sartorius Lab Holding GmbH. The company is a small corporation as defined by Section 267 of the German Commercial Code (HGB). Pursuant to the Contribution and Assignment Agreement dated September 8, 2011, Sartorius AG contributed its 100% equity investment in Sartorius Weighing Technology GmbH, Goettingen, Germany, at book values of EUR 149.5 million into Sartorius Lab Holding GmbH. This contribution was made by way of contribution in kind in that a new share in Sartorius Lab Holding GmbH was granted. In the process, the share capital was increased from EUR 25 K (K = thousand) to EUR 5,000 K. The amount exceeding the share capital increase was transferred to the capital reserves. By shareholder resolution passed on December 16, 2011, Sartorius Weighing Technology distributed the shares it held in various subsidiaries at book values (carrying amounts) to Sartorius Lab Holding GmbH by way of a non-cash dividend. Afterwards, a distribution-induced writedown on the carrying amount of the equity investment in Sartorius Weighing Technology GmbH was made in the same amount. Sartorius Lab Holding GmbH operates as a holding company without operating activities of its own. 1. General Accounting and Valuation Principles The annual financial statements of Sartorius Lab Holding GmbH were prepared by applying the rules and regulations of the German Commercial Code (HGB) and of the German Law on Limited Liability Companies (GmbHG). 2. Structure of the Balance Sheet and the Income Statement To increase the clarity of the presentation, individual balance sheet and income statement items have been combined and reported separately in the Notes. The income statement was drawn up according to the expenditure type of presentation. 3. Currency Translation Liabilities in foreign currencies whose remaining term does not exceed one year are measured at the average spot rate valid on the reporting date. All other liabilities in foreign currencies are assessed at their conversion rate upon the invoice date or the higher average spot rate on the reporting date. 091749-001-01 / Sartorius Lab Holding GmbH / 2011 Notes to the Financial Statements 1.3 / 1

Receivables in foreign currencies whose remaining term does not exceed one year are measured at the average spot rate valid on the reporting date. All other receivables in foreign currencies are assessed at their conversion rate upon the invoice date or the higher average spot rate on the reporting date. 4. Financial Assets Shares in affiliated Participating companies interests Total in K in K in Gross book values as of Jan. 1, 2011 0 0 0 Investments 253,590 2,000 255,590 Disposals 0 0 0 Transfers 0 0 0 Gross book values as of Dec. 31, 2011 253,590 2,000 255,590 Impairment losses as of January 1, 2011 0 0 0 Impairment losses in 2011 101,820 0 101,820 Disposals 0 0 0 Additions 0 0 0 Impairment losses as of Dec. 31, 2011 101,820 0 101,820 Net book values as of Dec. 31, 2011 151,770 2,000 153,770 Net book values as of Dec. 31, 2010 0 0 0 Financial assets are measured at cost or at par value, unless they have to be reported at a lower recoverable amount on the balance sheet date. The investments primarily are additions from Sartorius AG's contribution of the shares in Sartorius Weighing Technology and of the shares of various subsidiaries, which were distributed by Sartorius Weighing Technology GmbH as a non-cash dividend to Sartorius Lab Holding GmbH. Furthermore, the additions include participating interests in subsidiaries, where such interests were purchased by the Sartorius Group as part of the acquisition of the Liquid Handling division of Biohit Oyj based in Finland. Impairment losses for the reporting year are related to the non-cash dividend previously described and concern the shares in Sartorius Weighing Technology GmbH. Please refer to the Major Affiliates and Ownership for the scope of consolidation and list of subsidiaries. 5. Trade and Other Receivables 2011 2010 in K in K Receivables from affiliated companies 54,626 0 Other receivables as assets 12,406 0 67,032 0 091749-001-01 / Sartorius Lab Holding GmbH / 2011 Notes to the Financial Statements 1.3 / 2

Trade and other receivables are reported so that all discernible risks are covered. Receivables from affiliated companies essentially consist of short-term loans, which were granted to 100% subsidiaries of Sartorius Lab Holding GmbH. Other receivables are comprised only of tax receivables. All trade and other receivables have a term of less than one year. 6. Notes to the Items of Issued Capital and Capital Reserves In the reporting year, the issued capital was raised from EUR 25 K by EUR 4,975 K to EUR 5,000 K as part of the contribution of the shares in Sartorius Weighing Technology GmbH based Goettingen, Germany, by Sartorius AG, likewise headquartered in Goettingen, Germany, by way of a contribution in kind. The capital reserves also resulted from the contribution of the equity investment in Sartorius Weighing Technology GmbH and are comprised only of the asset amount exceeding the share capital increase. 7. Retained Loss The retained loss consists of the loss carried forward of EUR 91.21 and the net loss of EUR 1,654,354.77 for fiscal 2011. 8. Provisions Provisions are recognized at the settlement amounts required. For existing interest hedges, a reserve of EUR 322 K had to be set up for anticipated losses due to incomplete contracts. The rules of Section 274 of HGB were applied voluntarily. 091749-001-01 / Sartorius Lab Holding GmbH / 2011 Notes to the Financial Statements 1.3 / 3

9. Liabilities This item consists of the following: Remaining Remaining Disclosed on term term balance sheet of more than of up to Dec. 31, 2011 five years one year in K in K in K Liabilities to banks 70,000 0 70,000 Trade payables 10 0 10 Payables to companies in which investments are held 2,241 0 2,241 Other liabilities 372 0 372 72,623 0 72,623 Liabilities are recognized at their settlement amounts. 10. Other Disclosures 10.1 Members of the Executive Board The managing directors of the company in the reporting year were as follows: Mr. Jens Michael Artelt, lawyer, resident of Rosdorf, Germany, until March 11, 2011 Dr. Joachim Kreuzburg, Graduate Engineer (Dipl.-Ingenieur), resident of Hanover, Germany, as of March 11, 2011 Jörg Pfirrmann, Graduate Economist (Dipl.-Ökonom), resident of Nörten-Hardenberg, Germany, as of March 11, 2011 Reinhard Vogt, (Industrial Business Manager (Industriekaufmann), resident of Dransfeld, Germany, as of March 3, 2011 The managing directors do not receive any remuneration for their activities in this capacity. 10.2 Loss Carried Forward The retained loss of EUR 1,654,445.98 will be carried forward to the new account. 091749-001-01 / Sartorius Lab Holding GmbH / 2011 Notes to the Financial Statements 1.3 / 4

10.3 Relationships with Affiliated Companies The annual financial statements of the company are consolidated in the Group financial statements of Sartorius Aktiengesellschaft, Goettingen, Germany. The Group financial statements of the company are published in the electronic German Federal Gazette (elektronische Bundesanzeiger) and are also available at www.sartorius.com. Goettingen, May 9, 2012 Original German-language version signed by the Management Disclaimer: This is a translation of the original German-language Notes to the 2011 Financial Statements of Sartorius Lab Holding GmbH. Sartorius shall not assume any liability for the correctness of this translation. The original German financial statements are the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. 091749-001-01 / Sartorius Lab Holding GmbH / 2011 Notes to the Financial Statements 1.3 / 5

Major Affiliates and Ownership in 2011 Sartorius AG's equity ownership in % Equity at Dec. 31, 2011 in K Net profit at Dec. 31, 2011 in K Sartorius Lab Holding GmbH, Goettingen, Germany 100.0 147927-1654 Sartorius Mechatronics Belgium N.V., Vilvoorde, Belgium 100.0-558 -192 Sartorius Mechatronics Nordic A/S, Taastrup, Denmark 100.0-211 -311 Biohit Deutschland GmbH, Rosbach, Germany 100.0-123 Sartorius Mechatronics UK Ltd., Epsom, U.K. 100.0 2078-128 Biohit Ltd., Torquay, U.K. 100.0 526 Sartorius Biohit LH Oy, Helsinki, Finland 100.0 6000 Sartorius Mechatronics France S.A.S, Palaiseau, France 100.0 1679-2576 Biohit S.A.S., Dourdan, France 100.0 1630 Sartorius Mechatronics Ireland Ltd., Dublin, Ireland 100.0 52-198 Sartorius Mechatronis Italy S.r.L., Florence, Italy 100.0 1015 46 Sartorius Mechatronics Netherlands B.V., Nieuwegein, Netherlands 100.0 144 502 Sartorius Mechatronics Austria GmbH, Vienna, Austria 100.0 3349 341 Sartorius Mechatronics Poland Sp. z.o.o., Kostrzyn, Poland*) 100.0 546-14 Biohit OOO, St. Petersburg, Russia 100.0 653 Denver Instrument GmbH, Goettingen, Germany 100.0 1639 156 Sartorius North America Inc., Bohemia, New York, USA 100.0 25005 0 Sartorius Mechatronics Corporation, Bohemia, New York, USA 100.0 6105-1230 Sartorius TCC Company, Arvada, Colorado, USA 100.0 6930 193 Biohit Inc., Neptune, New Jersey, USA 100.0-442 Sartorius Mechatronics Canada Inc., Mississauga, Canada 100.0 139 28 Sartorius Mechatronics Australia Pty. Ltd., Dandenong South, Victoria, Australia 100.0 370 283 Denver Instrument (Beijing) Co., Limited Beijing, China 100.0 5640 239 Sartorius Scientific Instruments (Beijing) Co. Ltd., Beijing, China 100.0 20668 4366 along with its subsidiary: Biohit Biotech (Suzhou) Co. Ltd., Shanghai, China 100.0 985 Sartorius Mechatronics Hong Kong Ltd., Kowloon, Hong Kong 100.0 3659 409 along with its subsidiary: Sartorius Mechatronics Korea Ltd., Seoul, South Korea 100.0 3320 548 Sartorius Weighing India Pvt. Ltd., Bangalore, India 100.0 1 0 along with its subsidiary: Biohit Biotech Systems (India) Pvt. Ltd., Chennai, India 100.0 33 Sartorius Mechatronics Japan K.K., Tokyo, Japan 100.0 8026 1489 along with its subsidiary: Biohit Japan Co. Ltd., Tokyo, Japan 100.0-910 Sartorius Mechatronics Singapore Pte. Ltd., Singapore 100.0 873 300 091749-001-01 / Sartorius Lab Holding GmbH / 2011 Notes to the Financial Statements 1.3 / 6

Sartorius Mechatronics (Thailand) Co. Ltd., Bangkok, Thailand 49.0 479 195 Sartorius Argentina S.A., Buenos Aires, Argentina*) 99.0 591 212 Sartorius do Brasil Ltda., Sao Paulo, Brazil *) 100.0-1367 -577 Sartorius Weighing Technology GmbH, Goettingen, Germany 100.0 44977-2760 SI Grone 1-Verwaltungs-GmbH, Goettingen, Germany 100.0 24-1 SIV Grone 1 GmbH & Co. KG, Goettingen, Germany 100.0 5500 49 Sartorius Mechatronics Philippines Inc., Makati City, Philippines 100.0 389 41 Sartorius de México S.A. de C.V., Naucalpan, Mexico *) 99.0 252 38 Sartorius Weighing India Pvt. Ltd., Bangalore, India Sartorius Mechatronics Switzerland AG, Dietikon, Switzerland 100.0-208 114 Sartorius Mechatronics Spain S.A., Madrid, Spain 100.0-1212 -417 Sartorius Mechatronics Hungaria Kft., Budapest, Hungary*) 100.0 754 116 As the financial statements of the subsidiaries identified by an *) were not available at the time our annual financial statements were prepared, the information from the annual financial statements of 2010 were considered. 091749-001-01 / Sartorius Lab Holding GmbH / 2011 Notes to the Financial Statements 1.3 / 7